BLTE – belite bio, inc - american depositary shares (US:NASDAQ)
Stock Stats
News
Belite Bio, Inc (NASDAQ: BLTE) had its price target raised by analysts at Maxim Group from $60.00 to $110.00. They now have a "buy" rating on the stock.
Belite Bio, Inc (NASDAQ: BLTE) had its price target raised by analysts at HC Wainwright from $60.00 to $100.00. They now have a "buy" rating on the stock.
Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
Belite Bio to Host Webcast on November 12, 2024, to Discuss Third Quarter 2024 Financial Results
Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds
Form 144 BELITE BIO, INC Filed by: Liaw Wei-Cheng
Form 144 BELITE BIO, INC Filed by: MATA NATHAN L.
Form 6-K BELITE BIO, INC For: Nov 12
Form 6-K BELITE BIO, INC For: Nov 04
Form 144/A BELITE BIO, INC Filed by: Lin Yu-Hsin
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.